Literature DB >> 8206989

Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid.

G Allenby1, R Janocha, S Kazmer, J Speck, J F Grippo, A A Levin.   

Abstract

Both 9-cis-retinoic acid (RA) and all-trans-RA (t-RA) compete for [3H]9-cis-RA binding to RA receptors (RAR alpha, beta, and gamma) in nucleosol fractions from transiently transfected COS-1 cells with IC50 values of approximately 12 and 5 nM, respectively. Curiously, 9-cis-RA competes for [3H]t-RA binding to mouse RAR alpha, beta, and gamma with IC50 values of 31, 8, and 60 nM, respectively, while t-RA itself does not exhibit such differential competition (IC50 values for RARs, 5 nM). A similar pattern is observed with human retinoic acid receptors (RARs). Differential binding of 9-cis-RA to the RAR beta and gamma receptors is also found following in vitro transcription and translation of these receptors. Displacement assays demonstrate that t-RA exhibits similar off-rates for RAR alpha, beta, and gamma. However, 9-cis-RA is 6-fold more rapidly displaced from RAR gamma than from RAR beta. When RAR-transfected COS-1 cells are incubated with [3H]t-RA, [3H]-9-cis-RA or various mixtures of these two radioligands, high performance liquid chromatography analysis demonstrates that the ligands bound in nucleosol fractions from RAR beta-transfected cells reflect the isomer content of the media. However, in identical whole cell assays, nucleosol fractions from RAR gamma-transfected cells preferentially bind t-RA over 9-cis-RA, consistent with the in vitro data. These binding kinetics in vitro and in whole cells suggest that there could be differences in the interactions of the receptor subtypes with the endogenous retinoic acids under physiologic conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206989

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  9-Cis-retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein.

Authors:  Hui Shen; Yu Luo; Chi-Chung Kuo; Xiaolin Deng; Chen-Fu Chang; Brandon K Harvey; Barry J Hoffer; Yun Wang
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

2.  Metabolism to a response pathway selective retinoid ligand during axial pattern formation.

Authors:  W W Pijnappel; G E Folkers; W J de Jonge; P J Verdegem; S W de Laat; J Lugtenburg; H F Hendriks; P T van der Saag; A J Durston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Retinoid receptor-based signaling plays a role in voltage-dependent inhibition of invertebrate voltage-gated Ca2+ channels.

Authors:  Eric de Hoog; Mark K Lukewich; Gaynor E Spencer
Journal:  J Biol Chem       Date:  2019-05-02       Impact factor: 5.157

Review 4.  From carrot to clinic: an overview of the retinoic acid signaling pathway.

Authors:  Maria Theodosiou; Vincent Laudet; Michael Schubert
Journal:  Cell Mol Life Sci       Date:  2010-02-07       Impact factor: 9.261

5.  Cellular retinoic acid-binding proteins are essential for hindbrain patterning and signal robustness in zebrafish.

Authors:  Anna Q Cai; Kelly Radtke; Angela Linville; Arthur D Lander; Qing Nie; Thomas F Schilling
Journal:  Development       Date:  2012-06       Impact factor: 6.868

6.  Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase.

Authors:  Justin D Lutz; Vaishali Dixit; Catherine K Yeung; Leslie J Dickmann; Alex Zelter; Jayne E Thatcher; Wendel L Nelson; Nina Isoherranen
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

7.  4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptors.

Authors:  C C Achkar; F Derguini; B Blumberg; A Langston; A A Levin; J Speck; R M Evans; J Bolado; K Nakanishi; J Buck; L J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 8.  The efficacy of 9-cis retinoic acid in experimental models of cancer.

Authors:  M M Gottardis; W W Lamph; D R Shalinsky; A Wellstein; R A Heyman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Authors:  S L Surman; R R Penkert; B G Jones; R E Sealy; J L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2016-01-06

10.  Density functional and docking studies of retinoids for cancer treatment.

Authors:  Carlos H T P Silva; Paulo Almeida; Carlton A Taft
Journal:  J Mol Model       Date:  2003-11-22       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.